Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
EV/Core EBITDA

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 58.3639.8458.8548.3742.83

What is the latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA ?

The latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA is 58.36 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202458.36
Mar202339.84
Mar202258.85
Mar202148.37
Mar202042.83

How is EV/Core EBITDA of ASTRAZENECA PHARMA INDIA Trending?

Years EV/Core EBITDA % Change
Mar2024 58.36
46.49
Mar2023 39.84
-32.30
Mar2022 58.85
21.67
Mar2021 48.37
12.93
Mar2020 42.83 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare EV/Core EBITDA ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹17,324.9 Cr -0.3% 8.6% 8.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,135.0 Cr 2.6% -1.1% 38.3% Stock Analytics
DIVIS LABORATORIES ₹153,074.0 Cr -3.8% -1.9% 60.1% Stock Analytics
CIPLA ₹114,019.0 Cr -2.4% -5.2% 10.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,192.0 Cr -5.9% -9.6% 14.5% Stock Analytics
ZYDUS LIFESCIENCES ₹96,256.3 Cr -3.9% -0.3% 40.6% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

-0.3%

8.6%

8.6%

SENSEX

-0.6%

-2.9%

6.3%


You may also like the below Video Courses